Become a partner

dubbelblind, randomiserad, kontrollerad klinisk prövning (double-blind RCT)

double-blind, randomized, controlled clinical trial [ENGLISH]

A clinical trial in which the researchers randomly divide study participants into a group receiving the experimental intervention and a group receiving standard or no treatment. Neither group knows how it has been assigned. This practice reduces the chance for a “placebo effect,” in which a treatment with no active ingredient produces results expected from a treatment with an active ingredient.

dubbelblind, randomiserad, kontrollerad klinisk prövning [SWEDISH]

En klinisk prövning där forskarna slumpvis fördelar studiedeltagarna i en grupp som får den experimentella interventionen och en grupp som får standardbehandling eller ingen behandling. Ingen av grupperna vet hur den har tilldelats. Denna praxis minskar risken för en "placeboeffekt", där en behandling utan aktiv ingrediens ger resultat som förväntas av en behandling med en aktiv ingrediens.


Resources and references

Definitions have been translated into the Swedish language from the following sources:

  1. 1. American Society of Gene and Cell Therapy Glossary
  2. 2. Clinical Trials Information System
  3. 3. EMA Glossary of Regulatory Terms
  4. 4. EMA Medical Terms simplifier
  5. 5. Glossary of Terms used in EU Clinical Trials Register
  6. 6. Glossary of Terms U.S Food and Drug Administration
  7. 7. National Human Genome Research Institute “Talking Glossary of Genomic and Genetic Terms”
  8. 8. The Glossary for Advanced Therapies Regen. Med. Dec 2020 Vol. 15 No. 12 Suppl. 1
  9. 9. Toolkit For Patient Focused Therapy Development Glossary

Feedback and comments on the word description